Medroxyprogesterone acetate (MPA), also known as depot medroxyprogesterone acetate (DMPA) in injectable form and sold under the brand name Depo-Provera among others, is a …

2024年9月26日 · Depot medroxyprogesterone acetate (DMPA, also known as DepoProvera) is an injectable progestin-only contraceptive that provides highly effective, private, three-month-long …

Unexpected vaginal bleeding during therapy with MPA should be investigated. MPA may cause some degree of fluid retention, therefore, caution should be exercised in treating any patient …

2020年11月12日 · MPA depot injection can decrease bone mineral density, possibly irreversible in postmenopausal women. Calcium and vitamin D supplementation are recommended.

Depot medroxyprogesterone acetate (DMPA) is an injectable contraceptive that has been used by approximately 1 in 5 adolescents and adult women in the United States who have had sex 1. …

Depo-Provera CI (medroxyprogesterone acetate [MPA]) inhibits the secretion of gonadotropins which primarily prevents follicular maturation and ovulation and causes thickening of cervical …

2022年1月6日 · Injectable DMPA should be given intramuscularly 100 mg every 2 weeks for at least 6 months and DMPA can also be given intramuscularly 150 mg every 3 months in …

MPA in a concentration of 150 mg/ml is available for depot contraceptive use in single-dose, 1 ml vials; injection with a 21- or 23-gauge needle is appropriate. A higher concentration depot …

Depot medroxyprogesterone acetate (DMPA) is an aqueous suspension of 17-acetoxy 6-methyl progestin administered by intramuscular injection for long-term contraception. This highly …

Fertigspritze (1 ml) Depo-Clinovir enthält 150 mg Medroxyprogesteronacetat (MPA) in steriler wässriger Suspension. Vollständige Auflistung der sonstigen Be-standteile, siehe Abschnitt 6.1.